Applications of Cis-Epoxysuccinic Acid in Industrial Manufacturing

As the direct manufacturer of cis-epoxysuccinic acid (CESA), we support high-performance requirements across a range of industrial sectors. Our expertise in synthesis, QC, and downstream compliance enables precise alignment of CESA with advanced production needs. The following application scenarios demonstrate real-world, field-proven deployment of CESA with a focus on targeted end-use, regulatory frameworks, integration in process streams, and finished goods output.

1. Synthetic L-Aspartic Acid Production

Cis-epoxysuccinic acid is a precedent-setting intermediate in the industrial synthesis of L-aspartic acid via enzymatic hydrolysis or chemical processing. This route remains critical for pharmaceutical and fine chemical manufacturers, as it circumvents dependence on microbial fermentation. Our product meets the tight stereochemical purity demanded by this pathway, safeguarding crucial product specifications through every batch.

Industry compliance standards

• USP (United States Pharmacopeia) monograph for L-Aspartic Acid
• European Pharmacopoeia 10.0, 2.2.24
• GMP EU Guidelines Part I: Chapter 5
• Chinese Pharmacopoeia (ChP) 2020 Edition

Typical usage ratio

• Entry levels average 1.03–1.10 molar equivalents to the target aspartic acid synthesis; optimized based on enzyme/catalyst system and downstream yield constraints

Downstream process integration

• Batch or continuous-flow hydrolysis with hydrolases, followed by purification through crystallization and centrifugation; CESA charged after primary pH adjustment as initial substrate

Final product types

• API (Active Pharmaceutical Ingredient) grade L-aspartic acid
• Food-grade amino acid additives
• Bio-based chemical intermediates for peptide synthesis

2. Polyaspartic Acid Polymers for Water Treatment

Industrial-scale production of polyaspartic acid, used as a biodegradable scale inhibitor, relies on CESA as a direct monomer source. The material’s high reactivity streamlines condensation polymerization processes, enabling tight molecular weight control and reducing by-product formation. Facilities utilizing this chemistry meet international benchmarks for effluent biodegradation and treatment agent safety.

Industry compliance standards

• ANSI/NSF Standard 60 for Drinking Water Treatment Chemicals
• REACH Registration (EU 1907/2006)
• China Sanitary Standard for Drinking Water Additives (GB 5749-2022)
• ISO 9001:2015 Certified Production

Typical usage ratio

• Implemented at 100 wt% of total monomer content; ratio with co-monomers (if used) adjusted to specification, with pure polyaspartic acid requiring CESA as sole precursor

Downstream process integration

• Thermal condensation or microwave-assisted ring opening, charged with controlled molar amount of CESA post-neutralization; reaction aqueous medium

Final product types

• Scale inhibitor polymers for RO membrane systems
• Corrosion prevention formulations for industrial circulating water
• Dispersants for municipal and wastewater treatment

3. Biodegradable Superabsorbent Polymer Synthesis

Advanced SAP (superabsorbent polymer) manufacturers, especially those focusing on bio-based alternatives for hygiene or medical applications, use CESA as a functionalized cross-linker to introduce hydrophilicity and degradability in acrylic or starch-based networks. The unique bifunctional epoxide/acid site allows process engineers to tailor gel properties for strict absorption, safety, and degradation benchmarks in regulated environments.

Industry compliance standards

• ISO 10993-5: Biological Evaluation for Medical Devices
• FDA 21 CFR 177.1210 (Polymers for Food Contact)
• OEKO-TEX® Standard 100 (Textile Safety)
• EN 13432: Compostability of Packaging

Typical usage ratio

• 0.1–2.5 wt% of total polymer mass, varied according to intended cross-link density and targeted swelling performance of finished SAP

Downstream process integration

• In-situ blending during radical polymerization of acrylic/starch backbone, introduced after neutralization stages to enable covalent network formation

Final product types

• Compostable superabsorbent core for hygiene pads and diapers
• Biodegradable SAPs for horticultural water retention
• Bio-based wound dressings with controlled degradation

4. Chiral Building Block for Agrochemical Synthesis

Major crop-protection chemical producers utilize CESA as a precursor chiral building block in asymmetric synthesis pipelines. Leveraging its defined stereochemistry, manufacturers integrate the raw material to construct optically active intermediates for high-value herbicides and specialty pesticides, enabling patented active ingredient formulations and tight regulatory submissions worldwide.

Industry compliance standards

• FAO/WHO Specification for Pesticide Technical Grade
• EPA Pesticide Registration Manual (Subpart D – Data Requirements for Chiral Chemicals)
• China ICAMA GB 2763 Maximum Residue Limits
• ISO 17025: Testing and Calibration Laboratory Accreditation

Typical usage ratio

• 0.5–1.2 molar equivalent relative to targeted chiral intermediate, with adjustments based on route selectivity and minimization of racemic by-products

Downstream process integration

• Entry step for stereoselective ring-opening reactions, followed by downstream functionalizations (amide formation, alkylation, cyclization); purity of CESA ensures correct absolute configuration

Final product types

• Enantiopure active ingredients for herbicides
• Chirally pure pesticide intermediates
• Patented specialty agrochemicals

5. Starting Material for N-Carboxyanhydride (NCA) Monomer Synthesis

Specialty polymer manufacturers and research labs employ CESA in the multi-step synthesis of N-carboxyanhydrides, notably for polypeptide engineering and precision biomedical research. The specificity and controlled reactivity of CESA support high-yield coupling to protected amino acid backbones, improving reproducibility and increasing quality of final NCAs critical for controlled polymerization protocols.

Industry compliance standards

• GMP (Good Manufacturing Practice) for APIs and Investigational Medicinal Products
• ISO 13485:2016 for Medical Devices R&D
• ICH Q7 Good Manufacturing Practice Guidance
• USP <1045> Biologics Manufacturing

Typical usage ratio

• 1.0–1.1 equivalents per amino acid unit in NCA monomer synthesis sequence; small excess to ensure complete conversion in lab-scale or pilot-scale batch runs

Downstream process integration

• Direct charge after amino acid protection; CESA reacts in situ during base-mediated cyclization and is subsequently washed out during NCA isolation/purification step

Final product types

• Polypeptide NCA monomers
• High-purity NCAs for drug delivery vehicles
• Functionalized polymeric scaffolds for biomaterials research

6. Fine Chemical Derivatives for Pharmaceutical Research

Pharmaceutical intermediates manufacturers leverage CESA in constructing advanced fine chemicals where epoxide and dicarboxyl moieties serve as valuable functional handles. The material enables selective ring opening, salt formation, and heterocycle scaffolding required in both pilot and full-scale custom synthesis for candidates under drug discovery pipelines.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• EU EudraLex Volume 4 GMP for Pharmaceuticals
• US FDA Drug Master File Submission Requirements
• ISO 22716: Good Manufacturing Practices for Cosmetic Ingredients

Typical usage ratio

• Usage ranges from equimolar to 2.5 times target intermediate, application-dependent per reaction selectivity and final product requirements

Downstream process integration

• Inserted at the initial heterocycle formation or carboxyl protection step, with downstream purification via thin layer chromatography or HPLC to isolate targeted derivatives

Final product types

• Specialty heterocyclic intermediates
• Custom epoxide-based building blocks for drug libraries
• Active ingredient precursor chemicals